Abstract
Intracellular pathogens cause a wide spectrum of clinical disease ranging from mild self-limiting infections to chronic diseases and even acute life-threatening illnesses. T cell-mediated immunity is central to effective immune control of Leishmania infection and the role that B cells and antibodies play in promoting immunopathology during disease associated with chronic Leishmania infection is becoming more clear. However, the role that B cells and antibodies play during a successful immune response may be subtle and range from protecting the host from a robust cell-mediated response to enhancing immune effectiveness. The B cell response may therefore be a significant component of both ineffective and effective immunity to Leishmania infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Afonso, LC, Scott P (1993) Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun
Alexander J, Satoskar AR, Russell DG (1999) Leishmania species: models of intracellular parasitism. J Cell Sci
Anam K, Afrin F, Banerjee D, Pramanik N, Guha SK, Goswami RP, Saha SK, Ali N (1999) Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy. Infect Immun
Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol
Boggiatto PM., Ramer-Tait AE, Metz K, Kramer EE, Gibson-Corley K, Mullin K, Hostetter JM, Gallup JM, Jones DE, Petersen CA (2010) Immunologic indicators of clinical progression Âduring canine Leishmania infantum infection. Clin Vaccine Immunol
Buxbaum LU (2008) A detrimental role for IgG and FcgammaR in Leishmania mexicana infection. Immunol Res
Caravaca F, Munoz A, Pizarro JL, Saez de Santamaria J, Fernandez-Alonso J (1991) Acute renal failure in visceral leishmaniasis. Am J Nephrol
Carson C, Quinnell RJ, Day MJ, Courtenay O (2010) Comparison of monoclonal and polyclonal antibodies for the detection of canine IgG1 and IgG2, and associations with infection outcome in Leishmania infantum naturally infected dogs. Vet Immunol Immunopathol
Carvalho EM, Teixeira RS, Johnson WD (1981) Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun
Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson WD (1985) Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest
Carvalho EM, Bacellar OA, Reed S, Barral A, Rocha H (1988) Visceral leishmaniasis: a disease associated with inability of lymphocytes to activate macrophages to kill leishmania. Braz J Med Biol Res
Carvalho EM, Bacellar O, Brownell C, Regis T, Coffman RL, Reed SG (1994) Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol
Casadevall A (1998) Antibody-mediated protection against intracellular pathogens. Trends Microbiol
Casadevall A (2003). Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect Immun
Chen CW, Chang YH, Tsi CJ, Lin WW (2003) Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. J Immunol
Chu N, Thomas BN, Patel SR, Buxhaum LU (2010) IgG1 is pathogenic in Leishmania mexicana infection. J Immunol
Colmenares M, Constant SL, Kima PE, McMahon-Pratt D (2002). Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody. Infect Immun
Darrah PA, Hondalus MK, Chen Q, Ischiropoulos H, Mosser DM (2000) Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun
David CV, Craft N (2009) Cutaneous and mucocutaneous leishmaniasis. Dermatol Ther. 22:491–502
Deak E, Jayakumar A, Cho KW, Goldsmith-Pestana K, Dondji B, Lambris JD, McMahon-Pratt D (2010) Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation. Eur J Immunol
DeKrey GK., Jones JJ, Mbow ML, Brodskyn CI, Titus RG (2003) Short report: requirement of b cells for delayed type hypersensitivity-like pathology after secondary infection with Leishmania major in resistant C57BL/6 mice. Am J Trop Med Hyg
Desjeux P (2001) The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg
Dutra M, Martinelli R, de Carvalho EM, Rodrigues LE, Brito E, Rocha H (1985) Renal involvement in visceral leishmaniasis. Am J Kidney Dis
ElShafie AI, Elghazali G, Ronnelid J, Venge P (2006) Cystatin C as a marker of immune complex-associated renal impairment in a Sudanese population with visceral leishmaniasis. Am J Trop Med Hyg
Elshafie AI, Ahlin E, Mathsson L, ElGhazalI G, Ronnelid J (2007) Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis. J Immunol
Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM (2002) B cells regulate Âautoimmunity by provision of IL-10. Nat Immunol
Gallo P, Goncalves R, Mosser DM (2010) The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production. Immunol Lett
Ghosh AK, Dasgupta S, Ghose AC (1995) Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis. Clin Diagn Lab Immunol
Gibson-Corley KN, Boggiatto PM, Mukbel RM, Petersen CA, Jones DE (2010) A deficiency in the B cell response of C57BL/6 mice correlates with loss of macrophage-mediated killing of Leishmania amazonensis. Int J Parasitol
Gondwe EN, Molyneux ME, Goodall M, Graham SM, Mastroeni P, Drayson MT, MacLennan CA (2010) Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci USA
Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R (2010) Control systems and decision making for antibody production. Nat Immunol
Goto H, Prianti MG (2009) Immunoactivation and immunopathogeny during active visceral leishmaniasis. Rev Inst Med Trop Sao Paulo
Gumy A, Louis JA, Launois P (2004) The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds. Int J Parasitol
Gustavsson S, Hjulstrom-Chomez S, Lidstrom BM, Ahlborg N, Andersson R, Heyman B (1998) Impaired antibody responses in H-2Ab mice. J Immunol
Gustavsson S, Chomez S, Heyman B (1999) Low responsiveness to immunization with immunoglobulin E/antigen and immunoglobulin G/antigen complexes in H-2Ab mice. Scand J Immunol
Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE (2000) Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol
Hjelm F, Carlsson F, Getahun A, Heyman B (2006) Antibody-mediated regulation of the immune response. Scand J Immunol
Hostetter J, Huffman E, Byl K, Steadham E (2005) Inducible nitric oxide synthase immunoreactivity in the granulomatous intestinal lesions of naturally occurring bovine Johne’s disease. Vet Pathol
Igietseme JU, Eko FO, He Q, Black CM (2004) Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens. Expert Rev Vaccines
Ji J, Sun J, Qi H, Soong L (2002) Analysis of T helper cell responses during infection with Leishmania amazonensis. Am J Trop Med Hyg
Ji J, Sun J, Soong L (2003) Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun
Joller N, Weber SS, Muller AJ, Sporri R, Selchow P, Sander P, Hilbi H, Oxenius (2010) Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting. Proc Natl Acad Sci USA
Kharazmi A, Rezai HR, Fani M, Behforouz NC (1982) Evidence for the presence of circulating immune complexes in serum and C3b and C3d on red cells of kala-azar patients. Trans R Soc Trop Med Hyg
Kima PE, Constant SL, Hannum L, Colmenares M, Lee KS, Haberman AM, Shlomchik MJ, McMahon-Pratt D (2000) Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med
Leandro C, Santos-Gomes GM, Campino L, Romao P, Cortes S, Rolao N, Gomes-Pereira S, Rica Capela MJ, Abranches P (2001) Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis. Vet Immunol Immunopathol
Linares E, Giorgio S, Mortara RM, Santos CX, Yamada AT, Augusto O (2001) Role of peroxynitrite in macrophage microbicidal mechanisms in vivo revealed by protein nitration and hydroxylation. Free Radic Biol Med
Louis J, Himmelrich H, Parra-Lopez C, Tacchini-Cottier F, Launois P (1998) Regulation of protective immunity against Leishmania major in mice. Curr Opin Immunol
Makni S, Ayed K, Ben Said M, Ben Rachid MS (1989) Study of circulating immune complexes during the evolution of visceral Mediterranean leishmaniasis. Ann Trop Med Parasitol
Manca F, Fenoglio D, Kunkl A, Cambiagg Ci, Sasso M, Celada F (1988) Differential activation of T cell clones stimulated by macrophages exposed to antigen complexed with monoclonal Âantibodies. A possible influence of paratope specificity on the mode of antigen processing. J Immunol
Marcussen N, Vetner M, Kristensen HM (1989) Interstitial nephritis and glomerulonephritis in visceral leishmaniasis in a dog. A case report. Apmis
Mary C, Ange G, Dunan S, Lamouroux D, Quilici M (1993) Characterization of a circulating antigen involved in immune complexes in visceral leishmaniasis patients. Am J Trop Med Hyg
Miles SA, Conrad SM, Alves RG, Jeronimo SM, Mosser DM (2005) A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med
Mitropoulos P, Konidas P, Durkin-Konidas M (2010) New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment. J Am Acad Dermatol
Mizoguchi A, Bhan AK (2006) A case for regulatory B cells. J Immunol. 176:705–710
Moore, T., G.A. Ananaba, J. Bolier, S. Bowers, T. Belay, F.O. Eko, and J.U. Igietseme. 2002. Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology
Moore T, Ekworomadu CO, Eko FO, MacMillan L, Ramey K, Ananaba GA, Patrickson JW, Nagappan PR, Lyn D, Black CM, and Igietseme JU (2003) Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J Infect Dis
Mukbel R, Petersen CA, Jones DE (2006) Soluble factors from Leishmania major-specific CD4+T cells and B cells limit L. amazonensis amastigote survival within infected macrophages. Microbes Infect
Mukbel RM., Patten C., Gibson K, Ghosh M, Petersen C, Jones DE (2007) Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide. Am J Trop Med Hyg
Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol
Nimmerjahn F, Ravetch JV (2010) Antibody-mediated modulation of immune responses. Immunol Rev
Nylen S, Akuffo H (2009) Tracing immunity to human leishmaniasis. Future Microbiol
Nylen S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, Sacks D (2007) Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med
Palanivel V, Posey C, Horauf AM, Solbach W, Piessens WF, Harn DA (1996) B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol
Parekh VV, Prasad DV, Banerjee PP, Joshi BN, Kumar A, Mishra CG (2003) B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1. J Immunol
Petersen CA (2009) Leishmaniasis, an emerging disease found in companion animals in the United States. Top Companion Anim Med
Petty RE, Steward MW, Soothill JF (1972) The heterogeneity of antibody affinity in inbred mice and its possible immunopathologic significance. Clin Exp Immunol
Pistoia V, Corcione A (1995) Relationships between B cell cytokine production in secondary lymphoid follicles and apoptosis of germinal center B lymphocytes. Stem Cells
Quinnell RJ, Courtenay O, Garcez LM, Kaye PM, Shaw MA, Dye C, Day MJ (2003) IgG subclass responses in a longitudinal study of canine visceral leishmaniasis. Vet Immunol Immunopathol
Ramer AE, Vanloubbeeck YF, Jones DE (2006) Antigen-Responsive CD4+ T Cells from C3H Mice Chronically Infected with Leishmania amazonensis Are Impaired in the Transition to an Effector Phenotype. Infect Immun
Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol
Saha S, Mondal S, Banerjee A, Ghose J, Bhowmick S, Ali N (2006) Immune responses in kala-azar. Indian J Med Res
Scott P, Natovitz P, Sher A (1986) B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis. J Immunol
Smelt SC, Cotterell SE, Engwerda CR, Kay PM (2000) B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J Immunol
Soong L, Chang CH, Sun J, Longley BJ, Ruddle NH, Flavell RA, McMahon-Pratt D (1997) Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J Immunol
Souza RM, de Oliveira IB, Paiva VC, Lima KC, dos Santos RP, de Almeida JB, Luz KG (2009) Presence of antibodies against Leishmania chagasi in haemodialysed patients. Trans R Soc Trop Med Hyg
Thomas BN, Buxbaum LU (2008) FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions. Infect Immun
Todoli F, Solano-Gallego L, de Juan R, Morell P, Nunez Mdel C, Lasa R, Gomez-Sebastian S, Escribano JM, Alberola J, Rodriguez-Cortes A (2010) Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area. Am J Trop Med Hyg
Underhill DM, Ozinsky A (2002) Phagocytosis of microbes: complexity in action. Annu Rev Immunol
Uppington H, Menager N, Boross P, Wood J, Sheppard M, Verbeek S, Mastroeni P (2006) Effect of immune serum and role of individual Fcgamma receptors on the intracellular distribution and survival of Salmonella enterica serovar Typhimurium in murine macrophages. Immunology
Vanloubbeeck YF, Ramer AE, Jie F, JonesDE (2004) CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing. Infect Immun
Wanasen N, Xin L, Soong L (2008) Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Int J Parasitol
Weisinger JR, PintoA, Velazquez GA, Bronstein I, Dessene JJ, Duque JF, Montenegro J, Tapanes F, de Rousse AR (1978) Clinical and histological kidney involvement in human kala-azar. Am J Trop Med Hyg
Woelbing F, Kostka SL, Moelle K, Belkaid Y, Sunderkoetter C, Verbeek S, Waisman A, Nigg AP, Knop J, Udey MC, von Stebut E (2006) Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med
Yager E, Bitsaktsis C, Nandi B, McBride JW, Winslow G (2005) Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice. Infect Immun
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Gibson-Corley, K.N., Petersen, C.A., Jones, D.E. (2012). B Cell-Mediated Regulation of Immunity During Leishmania Infection. In: Aliberti, J. (eds) Control of Innate and Adaptive Immune Responses during Infectious Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0484-2_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0484-2_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0483-5
Online ISBN: 978-1-4614-0484-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)